只使用免费官方源：SEC Forms 3/4/5 结构化内部人申报，以及 FINRA Consolidated NMS 场外卖空成交量。 两类数据均保留来源边界，不转写成买卖建议。
SEC 已完成季度 Forms 3/4/5 结构化历史基线 + EDGAR 当前季度 Form 4 增量；个股卡片仅展示当前自然季度的非衍生证券买卖代码 P/S（公开市场或私下交易），成交金额由股数 × 每股价格计算。
官方数据说明| 交易日 / 申报日 | 公司 | 申报人 | 类型 | 股数 | 每股价格 | 派生金额 | 持有后股数 | 原始申报 |
|---|---|---|---|---|---|---|---|---|
| 2026-07-21 2026-07-23 | MLYS Mineralys Therapeutics, Inc. | Warren Eric Officer · Chief Commercial Officer | 卖出（S） | 7,438 | US$26.87 | US$199,885.09 | 38,400 | SEC |
| 2026-07-17 2026-07-20 | MLYS Mineralys Therapeutics, Inc. | Rodman David Malcom Officer · Chief Medical Officer | 卖出（S） | 416 | US$26.53 | US$11,036.48 | 51,384 | SEC |
| 2026-07-15 2026-07-15 | MLYS Mineralys Therapeutics, Inc. | Rodman David Malcom Officer · Chief Medical Officer | 卖出（S） | 6,349 | US$26.61 | US$168,954.51 | 51,384 | SEC |
| 2026-07-13 2026-07-15 | MLYS Mineralys Therapeutics, Inc. | Rodman David Malcom Officer · Chief Medical Officer | 卖出（S） | 14,058 | US$27.58 | US$387,716.83 | 57,733 | SEC |
| 2026-07-13 2026-07-15 | MLYS Mineralys Therapeutics, Inc. | Congleton Jon Director,Officer · Chief Executive Officer | 卖出（S） | 10,700 | US$27.24 | US$291,441.25 | 603,621 | SEC |
| 2026-07-09 2026-07-10 | MLYS Mineralys Therapeutics, Inc. | Rodman David Malcom Officer · Chief Medical Officer | 卖出（S） | 2,171 | US$30.30 | US$65,781.30 | 57,733 | SEC |
| 2026-06-30 2026-06-30 | MLYS Mineralys Therapeutics, Inc. | Congleton Jon Director,Officer · Chief Executive Officer | 卖出（S） | 17,000 | US$26.82 | US$455,940.00 | 614,321 | SEC |
| 2026-06-30 2026-06-30 | MLYS Mineralys Therapeutics, Inc. | Congleton Jon Director,Officer · Chief Executive Officer | 卖出（S） | 58,000 | US$25.94 | US$150.45万 | 631,321 | SEC |
| 2026-06-26 2026-06-30 | MLYS Mineralys Therapeutics, Inc. | Warren Eric Officer · Chief Commercial Officer | 卖出（S） | 104,124 | US$25.90 | US$269.68万 | 38,400 | SEC |
| 2026-06-17 2026-06-17 | MLYS Mineralys Therapeutics, Inc. | Karydas Daphne Director | 卖出（S） | 3,000 | US$25.00 | US$75,000.00 | 6,200 | SEC |
| 2026-06-17 2026-06-17 | MLYS Mineralys Therapeutics, Inc. | Rodman David Malcom Officer · Chief Medical Officer | 卖出（S） | 4,584 | US$25.00 | US$114,600.00 | 57,095 | SEC |
| 2026-06-15 2026-06-17 | MLYS Mineralys Therapeutics, Inc. | Rodman David Malcom Officer · Chief Medical Officer | 卖出（S） | 9,890 | US$23.81 | US$235,480.90 | 57,095 | SEC |
| 2026-06-12 2026-06-12 | MLYS Mineralys Therapeutics, Inc. | Rodman David Malcom Officer · Chief Medical Officer | 卖出（S） | 6,349 | US$23.93 | US$151,931.57 | 63,443 | SEC |
| 2026-06-10 2026-06-12 | MLYS Mineralys Therapeutics, Inc. | Rodman David Malcom Officer · Chief Medical Officer | 卖出（S） | 2,170 | US$25.00 | US$54,250.00 | 63,443 | SEC |
| 2026-05-18 2026-05-19 | MLYS Mineralys Therapeutics, Inc. | Rodman David Malcom Officer · Chief Medical Officer | 卖出（S） | 417 | US$27.55 | US$11,488.35 | 63,443 | SEC |
| 2026-05-13 2026-05-13 | MLYS Mineralys Therapeutics, Inc. | Rodman David Malcom Officer · Chief Medical Officer | 卖出（S） | 14,056 | US$28.58 | US$401,720.48 | 63,443 | SEC |
| 2026-05-12 2026-05-13 | MLYS Mineralys Therapeutics, Inc. | Rodman David Malcom Officer · Chief Medical Officer | 卖出（S） | 6,348 | US$29.36 | US$186,377.28 | 69,792 | SEC |
| 2026-05-11 2026-05-13 | MLYS Mineralys Therapeutics, Inc. | Rodman David Malcom Officer · Chief Medical Officer | 卖出（S） | 2,171 | US$29.71 | US$64,500.41 | 69,792 | SEC |
| 2026-04-17 2026-04-21 | MLYS Mineralys Therapeutics, Inc. | Rodman David Malcom Officer · Chief Medical Officer | 卖出（S） | 416 | US$31.33 | US$13,033.28 | 69,792 | SEC |
| 2026-04-15 2026-04-15 | MLYS Mineralys Therapeutics, Inc. | Rodman David Malcom Officer · Chief Medical Officer | 卖出（S） | 6,348 | US$27.66 | US$175,585.68 | 69,792 | SEC |
| 2026-04-13 2026-04-15 | MLYS Mineralys Therapeutics, Inc. | Congleton Jon Director,Officer · Chief Executive Officer | 卖出（S） | 15,730 | US$26.83 | US$422,035.90 | 689,321 | SEC |
| 2026-04-13 2026-04-15 | MLYS Mineralys Therapeutics, Inc. | Rodman David Malcom Officer · Chief Medical Officer | 卖出（S） | 14,058 | US$26.54 | US$373,099.32 | 76,140 | SEC |
| 2026-04-09 2026-04-13 | MLYS Mineralys Therapeutics, Inc. | Rodman David Malcom Officer · Chief Medical Officer | 卖出（S） | 2,170 | US$27.38 | US$59,414.60 | 76,140 | SEC |
| 2026-03-31 2026-04-02 | MLYS Mineralys Therapeutics, Inc. | Congleton Jon Director,Officer · Chief Executive Officer | 卖出（S） | 19,364 | US$25.50 | US$493,782.00 | 760,687 | SEC |
| 2026-03-31 2026-04-02 | MLYS Mineralys Therapeutics, Inc. | Congleton Jon Director,Officer · Chief Executive Officer | 卖出（S） | 453 | US$27.05 | US$12,253.65 | 705,051 | SEC |
| 2026-03-31 2026-04-02 | MLYS Mineralys Therapeutics, Inc. | Congleton Jon Director,Officer · Chief Executive Officer | 卖出（S） | 55,183 | US$26.54 | US$146.46万 | 705,504 | SEC |
| 2026-03-31 2026-04-02 | MLYS Mineralys Therapeutics, Inc. | Karydas Daphne Director | 卖出（S） | 3,000 | US$25.00 | US$75,000.00 | 6,200 | SEC |
| 代码 | 卖空成交量 | 豁免卖空量 | 场外总成交量 | 卖空量占比 | 报告设施 |
|---|---|---|---|---|---|
| MLYS | 103,226.9488 | 0 | 210,476.0258 | 49.04% | B, Q, N |